Cargando…
An Omikron angepasster Impfstoff zugelassen
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Medizin
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663278/ https://www.ncbi.nlm.nih.gov/pubmed/36376693 http://dx.doi.org/10.1007/s15006-022-2110-6 |
| _version_ | 1784830837209956352 |
|---|---|
| author | Bublak, Robert |
| author_facet | Bublak, Robert |
| author_sort | Bublak, Robert |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9663278 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer Medizin |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96632782022-11-14 An Omikron angepasster Impfstoff zugelassen Bublak, Robert MMW Fortschr Med Pharmaforum Springer Medizin 2022-11-15 2022 /pmc/articles/PMC9663278/ /pubmed/36376693 http://dx.doi.org/10.1007/s15006-022-2110-6 Text en © Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Pharmaforum Bublak, Robert An Omikron angepasster Impfstoff zugelassen |
| title | An Omikron angepasster Impfstoff zugelassen |
| title_full | An Omikron angepasster Impfstoff zugelassen |
| title_fullStr | An Omikron angepasster Impfstoff zugelassen |
| title_full_unstemmed | An Omikron angepasster Impfstoff zugelassen |
| title_short | An Omikron angepasster Impfstoff zugelassen |
| title_sort | omikron angepasster impfstoff zugelassen |
| topic | Pharmaforum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663278/ https://www.ncbi.nlm.nih.gov/pubmed/36376693 http://dx.doi.org/10.1007/s15006-022-2110-6 |
| work_keys_str_mv | AT bublakrobert anomikronangepassterimpfstoffzugelassen AT bublakrobert omikronangepassterimpfstoffzugelassen |